The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Regioselective hydroxylation of steroid hormones by human cytochromes P450
Abstract
This article reviews in vitro metabolic activities [including Michaelis constants (Km), maximal velocities (Vmax) and Vmax/Km] and drug-steroid interactions [such as induction and cooperativity (activation)] of cytochromes P450 (P450 or CYP) in human tissues, including liver and adrenal gland, for 14 kinds of endogenous steroid compounds, including allopregnanolone, cholesterol, cortisol, cortisone, dehydroepiandrosterone, estradiol, estrone, pregnenolone, progesterone, testosterone and bile acids (cholic acid). First, we considered the drug-metabolizing P450s. 6β-Hydroxylation of many steroids, including cortisol, cortisone, progesterone and testosterone, was catalyzed primarily by CYP3A4. CYP1A2 and CYP3A4, respectively, are likely the major hepatic enzymes responsible for 2-/4-hydroxylation and 16α-hydroxylation of estradiol and estrone, steroids that can contribute to breast cancer risk. In contrast, CYP1A1 and CYP1B1 predominantly metabolized estrone and estradiol to 2- and 4-catechol estrogens, which are endogenous ultimate carcinogens if formed in the breast. Some metabolic activities of CYP3A4, including dehydroepiandrosterone 7β-/16α-hydroxylation, estrone 2-hydroxylation and testosterone 6β-hydroxylation, were higher than those for polymorphically expressed CYP3A5. Next, we considered typical steroidogenic P450s. CYP17A1, CYP19A1 and CYP27A1 catalyzed steroid synthesis, including hydroxylation at 17α, 19 and 27 positions, respectively. However, it was difficult to predict which hepatic drug-metabolizing P450 or steroidogenic P450 will be mainly responsible for metabolizing each steroid hormone in vivo based on these results. Further research is required on the metabolism of steroid hormones by various P450s and on prediction of their relative contributions to in vivo metabolism. The findings collected here provide fundamental and useful information on the metabolism of steroid compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic xenobiotic-metabolizing members of the CYP superfamily are able to modify steroid hormones and generate a plethora of minor steroid metabolites [116].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [116]
In the citing paper
“with at least 17 hepatic CYPs potentially participating in the metabolism of steroids [[116], [117], [118]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [116]
In the citing paper
“CYP3A4 is the most abundant P450 in the liver (∼30%) (Shimada et al., 1994) and predominantly, though not exclusively, catalyses the 6β-hydroxylation of T and the 16α- and 7α-hydroxylation of DHEA (Niwa et al., 2015).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Niwa et al., 2015
In the citing paper
“Prostate cells also express CYP3A4 that can inactivate T by conversion to mainly 6βOH-T (with 2β-, 15α/β- and 11β-hydroxyl side product formation (Niwa et al., 2015))”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Niwa et al., 2015
Citations
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Rendić, S., & Carlo, F. J. D. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037591 · Cited by 1,165
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. T. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 970
Summary of information on human CYP enzymes: human P450 metabolism data
Rendić, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 819
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
Williams, J. A., Ring, B. J., Cantrell, V. E., Jones, D. R., Eckstein, J., Ruterbories, K., Hamman, M. A., Hall, S. D., & Wrighton, S. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.883 · Cited by 471
Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003) · Endocrinology · doi:10.1210/en.2003-0192 · Cited by 457
Developmental Expression of the Major Human Hepatic CYP3A Enzymes
Stevens, J. C., Hines, R. N., Gu, C., Koukouritaki, S. B., Manro, J. R., Tandler, P. J., & Zaya, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054841 · Cited by 368
Gillam, E. M. J., Baba, T., Kim, B., Ohmori, S., & Guengerich, F. P. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1401 · Cited by 340
Yamazaki, H., & Shimada, T. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0302 · Cited by 310
Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
Spink, D. C. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.291 · Cited by 310
Purification and characterization of human placental aromatase cytochrome P-450.
Kellis, J. T., & Vickery, L. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61364-x · Cited by 290
Catalytic properties of polymorphic human cytochrome P450 1B1 variants
Shimada, T. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1607 · Cited by 272
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells
Russo, J., Lareef, M. H., Balogh, G., Guo, S., & Russo, I. H. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00390-x · Cited by 252
Isoherranen, N., & Thummel, K. E. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050245 · Cited by 239
Yamazaki, H., Nakamura, M., Komatsu, T., Ohyama, K., Hatanaka, N., Asahi, S., Shimada, N., Guengerich, F. P., Shimada, T., Nakajima, M., et al. (2002) · Protein Expression and Purification · doi:10.1006/prep.2001.1578 · Cited by 234
The role of cytochrome b5 in the biosynthesis of androgens by human P450c17
Katagiri, M., Kagawa, N., & Waterman, M. R. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1173 · Cited by 223
Multiple forms of human P450 expressed in Saccharomyces cerevisiae
Imaoka, S., Yamada, T., Hiroi, T., Hayashi, K., Sakaki, T., Yabusaki, Y., & Funae, Y. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00052-4 · Cited by 207
4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Diczfalusy, U., Nylén, H., Elander, P., & Bertilsson, L. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03773.x · Cited by 202
Badawi, A. F., Cavalieri, E. L., & Rogan, E. G. (2001) · Metabolism · doi:10.1053/meta.2001.25592 · Cited by 184
Yamazaki, H., Shaw, P. M., Guengerich, F. P., & Shimada, T. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970217f · Cited by 182
Flück, C. E., Miller, W. L., & Auchus, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030143 · Cited by 173
Cytochrome P450s and cholesterol homeostasis
Pikuleva, I. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.014 · Cited by 162
Isoform-Specific Regulation of Cytochromes P450 Expression by Estradiol and Progesterone
Choi, S.-Y., Koh, K. H., & Jeong, H. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046276 · Cited by 161
Kenworthy, K. E., Clarke, S. E., Andrews, J., & Houston, J. B. (2001) · PubMed · Cited by 160
Imai, T., Globerman, H., Gertner, J. M., Kagawa, N., & Waterman, M. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36570-6 · Cited by 153
Lee-Robichaud, P., Wright, J. N., Akhtar, M. E., & Akhtar, M. (1995) · Biochemical Journal · doi:10.1042/bj3080901 · Cited by 145
CHOLESTEROL-METABOLIZING CYTOCHROMES P450
Pikuleva, I. A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008789 · Cited by 133
Diczfalusy, U., Kanebratt, K. P., Bredberg, E., Andersson, T. B., Böttiger, Y., & Bertilsson, L. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03309.x · Cited by 130
Kerlan, V., Dréano, Y., Bercovici, J. P., Beaune, P. H., Floch, H. H., & Berthou, F. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90068-t · Cited by 129
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation
Cribb, A. E., Knight, M. J., Dryer, D., Guernsey, J., Hender, K., Tesch, M., & Saleh, T. M. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0801 · Cited by 118
Cholesterol 25-hydroxylation activity of CYP3A
Honda, A., Miyazaki, T., Ikegami, T., Iwamoto, J., Maeda, T., Hirayama, T. T., Saito, Y., Teramoto, T., & Matsuzaki, Y. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014084 · Cited by 115
Masimirembwa, C. M., Otter, C. A., Berg, M., Jönsson, M., Leidvik, B., Jonsson, E., Johansson, T., Bäckman, A., Edlund, A., & Andersson, T. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15034-9 · Cited by 106
Cytochromes P450: Roles in Diseases
Pikuleva, I. A., & Waterman, M. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.431916 · Cited by 106
Steroid Regulation of Drug-Metabolizing Cytochromes P450
Monostory, K., & Dvořák, Z. (2011) · Current Drug Metabolism · doi:10.2174/138920011795016854 · Cited by 105
Agrawal, V., Choi, J. H., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833e0cb5 · Cited by 105
Kinetic Analysis of the Three-step Steroid Aromatase Reaction of Human Cytochrome P450 19A1
Sohl, C. D., & Guengerich, F. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123711 · Cited by 103
Jansson, I., Stoilov, I., Sarfarazi, M., & Schenkman, J. B. (2001) · Pharmacogenetics · doi:10.1097/00008571-200112000-00007 · Cited by 101
Niwa, T., Yabusaki, Y., Honma, K., MATSUO, N., 龍田, 佳., Ishibashi, F., & KATAGIRI, M. (1998) · Xenobiotica · doi:10.1080/004982598239290 · Cited by 97
Progesterone Oxidation by Cytochrome P450 2D Isoforms in the Brain
Hiroi, T., Kishimoto, W., Chow, T., Imaoka, S., Igarashi, T., & Funae, Y. (2001) · Endocrinology · doi:10.1210/endo.142.9.8363 · Cited by 94
Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1174 · Cited by 91
Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain
Kishimoto, W., Hiroi, T., Shiraishi, M., Osada, M., Imaoka, S., Kominami, S., Igarashi, T., & Funae, Y. (2004) · Endocrinology · doi:10.1210/en.2003-1109 · Cited by 90
Mulatero, P., Curnow, K. M., Aupetit-Faisant, B., Foekling, M., Gomez-Sanchez, C., Veglio, F., Jeunemaitre, X., Corvol, P., & Pascoe, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5237 · Cited by 88
Usmani, K. A., Cho, T. M., Rose, R. L., & Hodgson, E. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010439 · Cited by 83
Wu, D. A., & Chung, B. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115334 · Cited by 80
Thomas, J. L., Duax, W. L., Addlagatta, A., Brandt, S., Fuller, R. R., & Norris, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304752200 · Cited by 77
Yamazaki, H., Niwa, T., Murayama, N., & Emoto, C. (2008) · Current Drug Metabolism · doi:10.2174/138920008783331121 · Cited by 75
Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells
Lu, F., Zahid, M., SAEED, M. K., Cavalieri, E. L., & Rogan, E. G. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.102 · Cited by 74
Peng, C.-C., Templeton, I. E., Thummel, K. E., Davis, C. N., Kunze, K. L., & Isoherranen, N. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.53 · Cited by 73
Miller, K. K. M., Cai, J., Ripp, S. L., Pierce, W. M., Rushmore, T. H., & Prough, R. A. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.305 · Cited by 73
Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
Nakamura, H., Nakasa, H., Ishii, I., Ariyoshi, N., Igarashi, T., Ohmori, S., & Kitada, M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.534 · Cited by 70
Choi, M. H., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003327 · Cited by 69
Papageorgiou, I. S., Grepper, S., & Unadkat, J. D. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049015 · Cited by 67
Role of a disordered steroid metabolome in the elucidation of sterol and steroid biosynthesis
Shackleton, C. H. L. (2012) · Lipids · doi:10.1007/s11745-011-3605-6 · Cited by 61
Heterotropic Cooperativity in Oxidation Mediated by Cytochrome P450
Niwa, T., Murayama, N., & Yamazaki, H. (2008) · Current Drug Metabolism · doi:10.2174/138920008784746364 · Cited by 60
Miyazaki, M., Nakamura, K., Fujita, Y., Guengerich, F. P., Horiuchi, R., & Yamamoto, K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021816 · Cited by 60
Characterization of stable human aromatase expressed in E. coli
Kagawa, N., Hori, H., Waterman, M. R., & Yoshioka, S. (2004) · Steroids · doi:10.1016/j.steroids.2004.01.002 · Cited by 59
Deo, A. K., & Bandiera, S. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022194 · Cited by 55
Metabolism of anabolic steroids by recombinant human cytochrome P450 enzymes
Rendić, S., Nolteernsting, E., & Schänzer, W. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00400-4 · Cited by 54
Role of cytochrome P450 in estradiol metabolism in vitro.
Cheng, Z., Shu, Y., Liu, Z., Wang, L., Ouyang, D., & Zhou, H.-H. (2001) · PubMed · Cited by 54
Mäenpää, J., Pelkonen, O., Cresteil, T., & Rane, A. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90152-m · Cited by 53
Schwarz, D., Kisselev, P., Schunck, W., Chernogolov, A. A., Boidol, W., Cascorbi, I., & Roots, I. (2000) · Pharmacogenetics · doi:10.1097/00008571-200008000-00005 · Cited by 53
Dehydroepiandrosterone Induces Human CYP2B6 through the Constitutive Androstane Receptor
Köhalmy, K., Tamási, V., Kob́ori, L., Sárváry, E., Pascussi, J., Porrogi, P., Rozman, D., Prough, R. A., Meyer, U., & Monostory, K. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016303 · Cited by 53
Lee, A. J., Conney, A. H., & Zhu, B. T. (2003) · PubMed · Cited by 49
Niwa, T., Hiroi, T., Tsuzuki, D., Yamamoto, S., Narimatsu, S., Fukuda, T., Azuma, J., & Funae, Y. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.06.030 · Cited by 45
Oxidation of Endobiotics Mediated by Xenobiotic-Metabolizing Forms of Human Cytochrome P450
Niwa, T., Murayama, N., & Yamazaki, H. (2009) · Current Drug Metabolism · doi:10.2174/138920009789895525 · Cited by 45
Nakamura, H., Torimoto, N., Ishii, I., Ariyoshi, N., Nakasa, H., Ohmori, S., & Kitada, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.4.432 · Cited by 44
Diversity and Substrate Specificity in the Structures of Steroidogenic Cytochrome P450 Enzymes
Sugimoto, H., & Shiro, Y. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.818 · Cited by 42
Niwa, T., Okada, K., Hiroi, T., Imaoka, S., Narimatsu, S., & Funae, Y. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.348 · Cited by 40
Oxidation of Dihydrotestosterone by Human Cytochromes P450 19A1 and 3A4
Cheng, Q., Sohl, C. D., Yoshimoto, F. K., & Guengerich, F. P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390047 · Cited by 40
Niwa, T., Shiraga, T., Yamasaki, S., Ishibashi, K., Ohno, Y., & Kagayama, A. (2003) · Xenobiotica · doi:10.1080/0049825031000121617 · Cited by 39
Inhibition of Human Cytochrome P450 3A4 by Cholesterol
Shinkyo, R., & Guengerich, F. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240457 · Cited by 33
Swinney, D. C. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08683-0 · Cited by 31
16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction
Storbeck, K., Swart, P., Africander, D., Conradie, R., Toit, R. L.-D., & Swart, A. C. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.016 · Cited by 28
Niwa, T., Murayama, N., & Yamazaki, H. (2011) · Current Drug Metabolism · doi:10.2174/138920011795495286 · Cited by 28
Ohmori, S., Fujiki, N., Nakasa, H., Nakamura, H., Ishii, I., Itahashi, K., & Kitada, M. (1998) · PubMed · Cited by 27
Interaction of CYP11B1 (cytochrome P‐45011β) with CYP11A1 (cytochrome P‐450scc) in COS‐1 cells
Cao, P., & Bernhardt, R. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00414.x · Cited by 26
A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio
Paracchini, V., Pedotti, P., Raimondi, S., GARTE, S. J., Bradlow, H. L., Sepkovic, D. W., & Taioli, E. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.119 · Cited by 25
Niwa, T., & Yamazaki, H. (2012) · Current Drug Metabolism · doi:10.2174/138920012802850092 · Cited by 24
Shet, M. S., Fisher, C., Tremblay, Y., Bélanger, A., Conley, A. J., Mason, J. I., & Estabrook, R. W. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701468391 · Cited by 21
Lee, S., & Goldstein, J. A. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-sh-030 · Cited by 20
Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterol
Diczfalusy, U., & Ingemar Björkhem, E. B. (2011) · Journal of Lipid Research · doi:10.1194/jlr.e017806 · Cited by 20
Comparison of Catalytic Properties of Cytochromes P450 3A4 and 3A5 by Molecular Docking Simulation
Niwa, T., Yasumura, M., Murayama, N., & Yamazaki, H. (2013) · Drug Metabolism Letters · doi:10.2174/1872312807666131229121228 · Cited by 18
Amino Acid Residues Affecting the Activities of Human Cytochrome P450 2C9 and 2C19
Niwa, T., Kageyama, A., Kishimoto, K., Yabusaki, Y., Ishibashi, F., & Katagiri, M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.931 · Cited by 16
New Aspects on Primary Aldosteronism
Enberg, U., Volpe, C., & Hamberger, B. (2003) · Neurochemical Research · doi:10.1023/a:1022341619943 · Cited by 15
Niwa, T., Murayama, N., & Yamazaki, H. (2010) · Eisei kagaku · doi:10.1248/jhs.56.239 · Cited by 12
Rais, N., Hussain, A., Chawla, Y. K., & Kohli, K. K. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.842 · Cited by 10
Niwa, T., Imamura, H., & Katagiri, M. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00080 · Cited by 2
Research works printed but not linked: 6
- Cheng Z, 2000, Acta Pharmacol Sin, 22, 148
- Kenworthy KE, 2001, Drug Metab Dispos, 29, 1644
- Lee AJ, 2003, Cancer Res, 63, 6532
- Mulatero P, 1998, J Clin Endocrinol Metab, 83, 3996
- Niwa T, 2009, Curr Drug Metab, 9, 20
- Ohmori S, 1998, Res Commun Mol Pathol Pharmacol, 100, 15
Cited by
Sorted by citations
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“2, hepatic xenobiotic-metabolizing members of the CYP superfamily are able to modify steroid hormones and generate a plethora of minor steroid metabolites [116].”
Sex‐specificity in lung cancer risk
Stapelfeld, C., Dammann, C., & Maser, E. (2019) · International Journal of Cancer · doi:10.1002/ijc.32716 · Cited by 225
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“Prostate cells also express CYP3A4 that can inactivate T by conversion to mainly 6bOH-T (with 2b-, 15a/b- and 11b-hydroxyl side product formation (Niwa et al., 2015)) and a decrease of CYP3A4 expression is observed in prostate cancer (Fujimura et al.”
Arzuaga, X., Smith, M. T., Gibbons, C. F., Skakkebæk, N. E., Yost, E. E., Beverly, B., Hotchkiss, A. K., Hauser, R. B., de Souza, R. P., Schrader, S. M., et al. (2019) · Environmental Health Perspectives · doi:10.1289/ehp5045 · Cited by 90
Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?
Charni‐Natan, M., Aloni-Grinstein, R., Osher, E., & Rotter, V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00374 · Cited by 91
Metadata
- Authors
- Niwa, T., Murayama, N., Imagawa, Y., & Yamazaki, H.
- Affiliations
- Shujitsu University (JP)
- Showa Pharmaceutical University (JP)
- Corresponding author
- Yamazaki, Hiroshi
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2015-02-13
- Volume
- 47
- Issue
- 2
- Pages
- 89-110
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2041685866
- Cited by
- 121
- References
- 88
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 7 · 2023: 12 · 2022: 18 · 2021: 10 · 2020: 13 · 2019: 14 · 2018: 5 · 2017: 10 · 2016: 10 · 2015: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Metabolism Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- steroid hormone metabolism, cytochrome P450, regioselective hydroxylation, CYP3A4, CYP1A2, CYP1A1, CYP1B1, CYP17A1, CYP19A1, CYP27A1, CYP3A5, enzyme induction, cooperativity, estradiol, estrone, catechol estrogens, breast cancer risk, steroidogenesis, adrenal gland, liver
- MeSH terms
- Adrenal Glands, Cholesterol, Cytochrome P-450 Enzyme System, Estradiol, Humans, Hydroxylation, Liver, Testosterone, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review